Filter
56
Filtered Results: 56
Text search:
Swaziland
Paediatric
HIV
G
uidelines
2010
Ministry
of
Health
and
Social
Welfare
Featured
Recommendations
3
New Publications
10
Language
Document type
No document type
44
Guidelines
5
Studies & Reports
4
Manuals
1
Training Material
1
Situation Updates
1
Countries / Regions
Eswatini/ Swaziland
7
Lesotho
5
Sierra Leone
1
Nigeria
1
Zimbabwe
1
Kenya
1
Tanzania
1
Rwanda
1
South Africa
1
Malawi
1
Mozambique
1
Africa
1
Southern Africa
1
Authors & Publishers
Publication Years
Category
Countries
17
Clinical Guidelines
6
Public Health
2
Pharmacy & Technologies
2
Women & Child Health
1
Toolboxes
HIV
21
TB
10
AMR
2
Caregiver
2
Pharmacy
1
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of...
FOLLOW-UP TO THE 2011 POLITICAL DECLARATION ON HIV/AIDS: INTENSIFYING EFFORTS TO ELIMINATE HIV/AIDS | Reporting Period: January – December 2014
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment ... from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expanding access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
Review
Drake AL et al. Journal of the International AIDS Society 2019, 22:e25271 http://onlinelibrary.wiley.com/doi/10.1002/jia2.25271/full | https://doi.org/10.1002/jia2.25271
Case Study on Improving HIV Testing and Services for Children Orphaned or made Vulnerable by HIV (OVC)
Regional Network for Equity in Health in east and southern Africa (EQUINET): Disussion Paper 112
The Essential Health Benefit (EHB) is known a...
The Essential Health Benefit (EHB) is known a...
Compendium of Case Studies
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a ... Development Group in conformity with WHO requirements for evidence-based policies.
The goal of this Global Action Plan is to articulate synergistic actions that will be required to prevent HIVDR from undermining efforts to achieve global targets on health ... HIV, and to provide the most effective treatment to all people living with HIV including adults, key populations, pregnant and breastfeeding women, children and adolescents. The Global Action Plan has five strategic objectives: 1) prevention and response; 2) monitoring and surveillance; 3) research and innovation; 4) laboratory capacity; and 5) governance and enabling mechanisms.
